111 related articles for article (PubMed ID: 12522812)
1. Human serum albumin incorporating synthetic heme: red blood cell substitute without hypertension by nitric oxide scavenging.
Tsuchida E; Komatsu T; Matsukawa Y; Nakagawa A; Sakai H; Kobayashi K; Suematsu M
J Biomed Mater Res A; 2003 Feb; 64(2):257-61. PubMed ID: 12522812
[TBL] [Abstract][Full Text] [Related]
2. Exchange transfusion with entirely synthetic red-cell substitute albumin-heme into rats: physiological responses and blood biochemical tests.
Huang Y; Komatsu T; Yamamoto H; Horinouchi H; Kobayashi K; Tsuchida E
J Biomed Mater Res A; 2004 Oct; 71(1):63-9. PubMed ID: 15368255
[TBL] [Abstract][Full Text] [Related]
3. Exchange transfusion with synthetic oxygen-carrying plasma protein "albumin-heme" into an acute anemia rat model after seventy-percent hemodilution.
Komatsu T; Yamamoto H; Huang Y; Horinouchi H; Kobayashi K; Tsuchida E
J Biomed Mater Res A; 2004 Dec; 71(4):644-51. PubMed ID: 15514927
[TBL] [Abstract][Full Text] [Related]
4. Albumin clusters: structurally defined protein tetramer and oxygen carrier including thirty-two iron(II) porphyrins.
Komatsu T; Oguro Y; Nakagawa A; Tsuchida E
Biomacromolecules; 2005; 6(6):3397-403. PubMed ID: 16283771
[TBL] [Abstract][Full Text] [Related]
5. Compatibility in vitro of albumin-heme (O(2) carrier) with blood cell components.
Huang Y; Komatsu T; Nakagawa A; Tsuchida E; Kobayashi S
J Biomed Mater Res A; 2003 Aug; 66(2):292-7. PubMed ID: 12888999
[TBL] [Abstract][Full Text] [Related]
6. Artificial oxygen carriers, hemoglobin vesicles and albumin-hemes, based on bioconjugate chemistry.
Tsuchida E; Sou K; Nakagawa A; Sakai H; Komatsu T; Kobayashi K
Bioconjug Chem; 2009 Aug; 20(8):1419-40. PubMed ID: 19206516
[TBL] [Abstract][Full Text] [Related]
7. PEGylated albumin-heme as an oxygen-carrying plasma expander: Exchange transfusion into acute anemia rat model.
Huang Y; Komatsu T; Yamamoto H; Horinouchi H; Kobayashi K; Tsuchida E
Biomaterials; 2006 Sep; 27(25):4477-83. PubMed ID: 16678256
[TBL] [Abstract][Full Text] [Related]
8. Influence of O(2)-carrying plasma hemoprotein "albumin-heme" on complement system and platelet activation in vitro and physiological responses to exchange transfusion.
Komatsu T; Huang Y; Wakamoto S; Abe H; Fujihara M; Azuma H; Ikeda H; Yamamoto H; Horinouchi H; Kobayashi K; Tsuchida E
J Biomed Mater Res A; 2007 Jun; 81(4):821-6. PubMed ID: 17236218
[TBL] [Abstract][Full Text] [Related]
9. Effects of recombinant-hemoglobin solutions rHb2.0 and rHb1.1 on blood pressure, intestinal blood flow, and gut oxygenation in a rat model of hemorrhagic shock.
Raat NJ; Liu JF; Doyle MP; Burhop KE; Klein J; Ince C
J Lab Clin Med; 2005 Jan; 145(1):21-32. PubMed ID: 15668658
[TBL] [Abstract][Full Text] [Related]
10. Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin.
Doherty DH; Doyle MP; Curry SR; Vali RJ; Fattor TJ; Olson JS; Lemon DD
Nat Biotechnol; 1998 Jul; 16(7):672-6. PubMed ID: 9661203
[TBL] [Abstract][Full Text] [Related]
11. Hemoglobin-vesicles suspended in recombinant human serum albumin for resuscitation from hemorrhagic shock in anesthetized rats.
Sakai H; Masada Y; Horinouchi H; Yamamoto M; Ikeda E; Takeoka S; Kobayashi K; Tsuchida E
Crit Care Med; 2004 Feb; 32(2):539-45. PubMed ID: 14758176
[TBL] [Abstract][Full Text] [Related]
12. No scavenging and the hypertensive effect of hemoglobin-based blood substitutes.
Olson JS; Foley EW; Rogge C; Tsai AL; Doyle MP; Lemon DD
Free Radic Biol Med; 2004 Mar; 36(6):685-97. PubMed ID: 14990349
[TBL] [Abstract][Full Text] [Related]
13. Fluid resuscitation with hemoglobin vesicles in a rabbit model of acute hemorrhagic shock.
Terajima K; Tsueshita T; Sakamoto A; Ogawa R
Shock; 2006 Feb; 25(2):184-9. PubMed ID: 16525358
[TBL] [Abstract][Full Text] [Related]
14. Human serum albumin incorporating Tetrakis(o-pivalamido) phenylporphinatoiron(II) derivative as a totally synthetic O2-carrying hemoprotein.
Tsuchida E; Komatsu T; Matsukawa Y; Hamamatsu K; Wu J
Bioconjug Chem; 1999; 10(5):797-802. PubMed ID: 10502345
[TBL] [Abstract][Full Text] [Related]
15. Reaction of nitric oxide with synthetic hemoprotein, human serum albumin incorporating tetraphenylporphinatoiron(II) derivatives.
Komatsu T; Matsukawa Y; Tsuchida E
Bioconjug Chem; 2001; 12(1):71-5. PubMed ID: 11170368
[TBL] [Abstract][Full Text] [Related]
16. O2-binding albumin thin films: solid membranes of poly(ethylene glycol)-conjugated human serum albumin incorporating iron porphyrin.
Nakagawa A; Komatsu T; Huang Y; Lu G; Tsuchida E
Bioconjug Chem; 2007; 18(5):1673-7. PubMed ID: 17696490
[TBL] [Abstract][Full Text] [Related]
17. [Artificial blood].
Kobayashi K
Nihon Geka Gakkai Zasshi; 2005 Jan; 106(1):31-7. PubMed ID: 15696696
[TBL] [Abstract][Full Text] [Related]
18. Resuscitation with a blood substitute causes vasoconstriction without nitric oxide scavenging in a model of arterial hemorrhage.
Fitzpatrick CM; Savage SA; Kerby JD; Clouse WD; Kashyap VS
J Am Coll Surg; 2004 Nov; 199(5):693-701. PubMed ID: 15501108
[TBL] [Abstract][Full Text] [Related]
19. Treatment with the arginase inhibitor N(omega)-hydroxy-nor-L-arginine improves vascular function and lowers blood pressure in adult spontaneously hypertensive rat.
Bagnost T; Berthelot A; Bouhaddi M; Laurant P; André C; Guillaume Y; Demougeot C
J Hypertens; 2008 Jun; 26(6):1110-8. PubMed ID: 18475148
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide mediates lung vascular permeability and lymph-borne IL-6 after an intestinal ischemic insult.
Breithaupt-Faloppa AC; Vitoretti LB; Coelho FR; dos Santos Franco AL; Domingos HV; Sudo-Hayashi LS; Oliveira-Filho RM; Tavares de Lima W
Shock; 2009 Jul; 32(1):55-61. PubMed ID: 18838940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
